Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - (amino acid solution) calcium chloride dihydrate corresp. to calcium chloride 0.56g; (amino acid solution) glycine (aminoacetic acid); (amino acid solution) l- histidine; (amino acid solution) l- isoleucine; (amino acid solution) l- leucine; (amino acid solution) l- methionine; (amino acid solution) l- serine; (amino acid solution) l- threonine; (amino acid solution) l- valine; (amino acid solution) l-alanine; (amino acid solution) l-arginine; (amino acid solution) l-lysine acetate corresp. to l-lysine 6.6g - emulsion - 0.740g per 1000ml - (amino acid solution) calcium chloride dihydrate corresp. to calcium chloride 0.56g 0.740g per 1000ml; (amino acid solution) glycine (aminoacetic acid) 11.0g per 1000ml; (amino acid solution) l- histidine 3.0g per 1000ml; (amino acid solution) l- isoleucine 5.0g per 1000ml; (amino acid solution) l- leucine 7.4g per 1000ml; (amino acid solution) l- methionine 4.3g per 1000ml; (amino acid solution) l- serine 6.5g per 1000ml; (amino acid solution) l- threonine 4.4g per 1000ml; (amino acid solution) l- valine 6.2g per 1000ml; (amino acid solution) l-alanine 14.0g per 1000ml; (amino acid solution) l-arginine 12.0g per 1000ml; (amino acid solution) l-lysine acetate corresp. to l-lysine 6.6g 9.3g per 1000ml; (amino acid solution) l-phenylalanine 5.1g per 1000ml; (amino acid solution) l-proline 11.2g per 1000ml; (amino acid solution) l-tryptophan 2.0g per 1000ml; (amino acid solution) l-tyrosine 0.40g per 1000ml; (amino acid solution) magnesium sulphate heptahydrate corresp. to magnesium sulphate 1.2g 2.47g per 1000m

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fresenius kabi malaysia sdn. bhd - isoleucine; arginine; leucine; histidine; methionine; phenylalanine; serine; threonine; tryptophan; valine; lysine acetate; medium chain triglycerides; glycine; glucose monohydrate; fish oil; olive oil; taurine; tyrosine.; soya bean oil, refined ph. eur; l-alanine; proline, -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fresenius kabi malaysia sdn. bhd - zinc sulphate.; tyrosine.; calcium chloride.; taurine; magnesium sulphate.; tryptophan; histidine; sodium acetate.; methionine; sodium glycerophosphate; potassium chloride.; threonine; isoleucine; phenylalanine; valine; serine; lysine; leucine; glycine; proline,; arginine; fish oil; alanine; olive oil; glucose monohydrate; medium chain triglycerides; soya bean oil. -

European Union - English - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - busulfan - hematopoietic stem cell transplantation - alkyl sulfonates - busulfan fresenius kabi followed by cyclophosphamide (bucy2) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation (hpct) in adult patients when the combination is considered the best available option.busulfan fresenius kabi followed by cyclophosphamide (bucy4) or melphalan (bumel) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation in paediatric patients.

European Union - English - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - pemetrexed - carcinoma, non-small-cell lung; mesothelioma - antineoplastic agents - malignant pleural mesotheliomapemetrexed fresenius kabi in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.non-small cell lung cancerpemetrexed fresenius kabi in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.pemetrexed fresenius kabi is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed fresenius kabi is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - alanine; arginine; fish oil, rich in omega -3 acids; glucose monohydrate; glycine; histidine; isoleucine; leucine; lysine acetate; methionine; olive oil, refined; phenylalanine; proline; serine; soya bean oil, refined; taurine; threonine; triglycerides, medium chain; tryptophan; tyrosine; valine - injection, emulsion - 14.0g/1000ml - alanine 14.0g/1000ml; arginine 12.0g /1000ml; fish oil, rich in omega -3 acids 30g /1000ml; glucose monohydrate 462g /1000ml; glycine 11.0g /1000ml; histidine 3.0g /1000ml; isoleucine 5.0g /1000ml; leucine 7.4g /1000ml; lysine acetate 9.3g /1000ml; methionine 4.3g /1000ml; olive oil, refined 50g /1000ml; phenylalanine 5.1g /1000ml; proline 11.2g /1000ml; serine 6.5g /1000ml; soya bean oil, refined 60.0g /1000ml; taurine 1.0g /1000ml; threonine 4.4g /1000ml; triglycerides, medium chain 60g /1000ml; tryptophan 2.0g/1000ml; tyrosine 0.4g /1000ml; valine 6.2g /1000ml

Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - alanine; arginine; calcium chloride dihydrate; fish oil, rich in omega -3 acids; glucose monohydrate; glycine; histidine; isoleucine; leucine; lysine acetate; magnesium sulphate heptahydrate; methionine; olive oil, refined; phenylalanine; potassium chloride; proline; serine; sodium acetate trihydrate; sodium glycerophosphate anhydrous; soya bean oil, refined; taurine; threonine; triglycerides, medium chain; tryptophan; tyrosine; valine; zinc sulphate heptahydrate - injection, emulsion - 14.0g/1000ml - alanine 14.0g/1000ml; arginine 12.0g /1000ml; calcium chloride dihydrate 0.74g /1000ml; fish oil, rich in omega -3 acids 30g /1000ml; glucose monohydrate 462g /1000ml; glycine 11.0g /1000ml; histidine 3.0g /1000ml; isoleucine 5.0g /1000ml; leucine 7.4g /1000ml; lysine acetate 9.3g /1000ml; magnesium sulphate heptahydrate 2.47g /1000ml; methionine 4.3g /1000ml; olive oil, refined 50g /1000ml; phenylalanine 5.1g /1000ml; potassium chloride 4.48g /1000ml; proline 11.2g /1000ml; serine 6.5g /1000ml; sodium acetate trihydrate 5.62g /1000ml; sodium glycerophosphate anhydrous 4.18g /1000ml; soya bean oil, refined 60.0g /1000ml; taurine 1.0g /1000ml; threonine 4.4g /1000ml; triglycerides, medium chain 60g /1000ml; tryptophan 2.0g/1000ml; tyrosine 0.4g /1000ml; valine 6.2g /1000ml; zinc sulphate heptahydrate 0.023g /1000ml

Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - alanine; arginine; calcium chloride dihydrate; fish oil, rich in omega -3 acids; glucose monohydrate; glycine; histidine; isoleucine; leucine; lysine acetate; magnesium sulphate heptahydrate; methionine; olive oil, refined; phenylalanine; potassium chloride; proline; serine; sodium acetate trihydrate; sodium glycerophosphate anhydrous; soya bean oil, refined; taurine; threonine; triglycerides, medium chain; tryptophan; tyrosine; valine; zinc sulphate heptahydrate - injection, emulsion - 14.0g/1000ml - alanine 14.0g/1000ml; arginine 12.0g /1000ml; calcium chloride dihydrate 0.74g /1000ml; fish oil, rich in omega -3 acids 30g /1000ml; glucose monohydrate 143g /1000ml; glycine 11.0g /1000ml; histidine 3.0g /1000ml; isoleucine 5.0g /1000ml; leucine 7.4g /1000ml; lysine acetate 9.3g /1000ml; magnesium sulphate heptahydrate 2.47g /1000ml; methionine 4.3g /1000ml; olive oil, refined 50g /1000ml; phenylalanine 5.1g /1000ml; potassium chloride 4.48g /1000ml; proline 11.2g /1000ml; serine 6.5g /1000ml; sodium acetate trihydrate 5.62g /1000ml; sodium glycerophosphate anhydrous 4.18g /1000ml; soya bean oil, refined 60.0g /1000ml; taurine 1.0g /1000ml; threonine 4.4g /1000ml; triglycerides, medium chain 60g /1000ml; tryptophan 2.0g/1000ml; tyrosine 0.4g /1000ml; valine 6.2g /1000ml; zinc sulphate heptahydrate 0.023g /1000ml

Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - calcium chloride dihydrate eqv. calcium chloride; fish oil, rich in omega-3 acids; glucose monohydrate eqv. glucose; glycine; l-alanine; l-arginine; l-histidine; l-isoleucine; l-leucine; l-lysine acetate equv. l-lysine; l-methionine; l-phenylalanine; l-proline; l-serine; l-threonine; l-tryptophan; l-tyrosine; l-valine; magnesium sulfate heptahydrate as magnesium sulfate; olive oil, refined; potassium chloride; sodium acetate trihydrate as sodium acetate; sodium glycerophosphate hydrated as sodium glycerophosphate; soy-bean oil, refined; taurine; triglycerides, medium-chain; zinc sulfate heptahydrate as zinc sulfate - injection, emulsion - calcium chloride dihydrate eqv. calcium chloride 0.28g/1000ml; fish oil, rich in omega-3 acids 4.3g/1000ml; glucose monohydrate eqv. glucose 85g/1000ml; glycine 7.2g/1000ml; l-alanine 9.2g/1000ml; l-arginine 7.9g/1000ml; l-histidine 2g/1000ml; l-isoleucine 3.3g/1000ml; l-leucine 4.8g/1000ml; l-lysine acetate equv. l-lysine 4.3g/1000ml; l-methionine 2.8g/1000ml; l-phenylalanine 3.3g/1000ml; l-proline 7.3g/1000ml; l-serine 4.3g/1000ml; l-threonine 2.9g/1000ml; l-tryptophan 1.3g/1000ml; l-tyrosine 0.26g/1000ml; l-valine 4.1g/1000ml; magnesium sulfate heptahydrate as magnesium sulfate 0.61g/1000ml; olive oil, refined 7.2g/1000ml; potassium chloride 2.3g/1000ml; sodium acetate trihydrate as sodium acetate 1.6g/1000ml; sodium glycerophosphate hydrated as sodium glycerophosphate 2.3g/1000ml; soy-bean oil, refined 8.7g/1000ml; taurine 0.65g/1000ml; triglycerides, medium-chain 8.7g/1000ml; zinc sulfate heptahydrate as zinc sulfate 0.0066g/1000ml

European Union - English - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - bortezomib - multiple myeloma - antineoplastic agents - bortezomib as monotherapy or in combination with pegylated liposomal doxorubicin or dexamethasone is indicated for the treatment of adult patients with progressive multiple myeloma who have received at least 1 prior therapy and who have already undergone or are unsuitable for haematopoietic stem cell transplantation.bortezomib in combination with melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for high-dose chemotherapy with haematopoietic stem cell transplantation.bortezomib in combination with dexamethasone, or with dexamethasone and thalidomide, is indicated for the induction treatment of adult patients with previously untreated multiple myeloma who are eligible for high-dose chemotherapy with haematopoietic stem cell transplantation.bortezomib in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.